Table 3. Associations* of a per-allele increase in TYMS rs495139 and risk of ovarian carcinoma types among white non-Hispanic subjects in OCAC.
Studies | Co | Serous | Mucinous | Endometrioid | Clear Cell | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ca | OR (95% CI) | P trend | Ca | OR (95% CI) | P trend | Ca | OR (95% CI) | P trend | Ca | OR (95% CI) | P trend | P value† | ||
15 OCAC studies‡ | 8,410 | 2,823 | 1.06 (1.00-1.13) | 0.05 | 354 | 1.19 (1.03-1.39) | 0.02 | 821 | 0.90 (0.81-0.99) | 0.04 | 409 | 0.86 (0.75-0.99) | 0.04 | 0.001 |
15 OCAC studies§ | 8,410 | 1,775 | 1.02 (0.94-1.10) | 0.68 | 204 | 1.26 (1.04-1.54) | 0.02 | 515 | 0.94 (0.83-1.07) | 0.36 | 409 | 0.86 (0.74-0.99) | 0.04 | 0.04 |
15 OCAC studies§, “re-assigned” type | 8,410 | 1,972 | 1.02 (0.95-1.09) | 0.62 | 183 | 1.32 (1.07-1.62) | 0.01 | 318 | 0.92 (0.78-1.08) | 0.29 | 409 | 0.86 (0.74-0.99) | 0.04 | 0.04 |
Co, controls; Ca, cases
Bold text indicates statistically significant associations
Adjusted for age and study
P for tumor heterogeneity
All OCAC studies including MAY and NCO1 but excluding MAL, which failed genotyping; samples do not total 5,593 cases and 9,962 controls from application of quality control criteria (see Methods) and exclusion of rarer histologies
Cases further restricted to samples with information on grade